Friday, February 10, 2012

Intensive Research Paving Way for miRNA Breakthroughs by Shushmul Maheshwari

According to our latest research offering “Global miRNA Market Outlook”, the miRNA industry is well set for stupendous growth in near future, on the back of substantiating research work being done in the field. Our in-depth analysis of the prevailing trends and strategies has revealed the current and future direction of the miRNA research around the globe. It is expected that, the academic and other research institutions will lead the way in the miRNA industry towards the development of new therapies and techniques. This would pave the way for companies providing miRNA products to support the commercialization of miRNA techniques in various application areas.

The report infers that, the research community is primarily focusing on the prediction and treatment of chronic diseases. Cancer, being a fatal cause of death, has attracted the attention of majority of researchers. Numerous papers have been published on the topic in the past, and a similar approach can be expected hereafter as well. The research work in this field has been mostly driven by the financial and infrastructural support of the respective regulatory authorities. Recently, the Medical Research Commercialization Fund (MRCF) has granted $650,000 to the Western Australian Institute for Medical Research (WAIMR) for miRNA research and to form a new company to act as a commercial vehicle.

“Global miRNA Market Outlook” is an outcome of extensive research and thorough analysis of the fast emerging miRNA field across the globe. To provide a comprehensive outlook of the target industry, a descriptive analysis of the past and current research work in the field of miRNA has been also included in the report.

Besides, the report discusses various techniques being applied for miRNA research and the products available in the market for the same. This would provide clients a clear idea of the developing competition in the miRNA products market at the global level.

For FREE SAMPLE of this report visit: